Peetu Tays

Paediatric Early Phase Clinical Trials Unit

The Paediatric Clinical Trials Unit (PeeTU) operates at the Tampere University Hospital and offers centralised clinical trial services (phase I-II) to children and adolescents in Finland.

Background & Aims:

The implementation of EU Paediatric Regulation (EY 1901/2006) has increased the need to investigate new medical products via clinical trials in the paediatric population. One major goal of the Paediatric Clinical Trials Unit is to provide access to early phase clinical trials for children with relapsed or refractory cancers. The research unit also aims to find novel medical agents and intervention tools to treat various other conditions in children and adolescents across paediatric subspecialties.

People:

The Paediatric Clinical Trials Unit is run by experts in the field of paediatrics and paediatric hematology and oncology, together with a team of study nurses. PeeTU also hosts medical doctors specializing in paediatrics as part of their training in pediatric clinical research. The Paediatric Clinical Trials Unit is based within the Tampere University Hospital.

Research themes:

– Early phase clinical trials for children with relapsed or refractory cancers
– Novel agents and therapeutic or diagnostic devices for childhood illnesses
– Treatment of relapsed and refractory Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia
– Study on the biology and genomics of acute leukemia in childhood
– Preventive treatment of episodic and chronic migraine in pediatric patients

Network:

PeeTU offers centralised clinical trial services to the whole Finnish paediatric population and works in close collaboration with Pediatric Clinics of other University Hospitals in Finland and the Finnish Investigators Network for Pediatric Medicines, FINPEDMED. The trial unit maintains close collaborative ties with the Nordic partners of the European ITCC-consortium (Innovative Therapies for Children with Cancer).

Learn more about the Paediatric Clinical Trials Unit (PeeTU).

Contact:

Director Sauli Palmu, Clinical Instructor, MD, PhD
Tampere University, Faculty of Medicine and Health Technology
sauli.palmu@tuni.fi
+358 50 353 9956
ARVO D519

Peetu trials